-
Product Name
RRM1 antibody
- Documents
-
Description
RRM1 Mouse Monoclonal antibody. Positive WB detected in K-562 cells. Positive IP detected in K-562 cells. Positive IF detected in HepG2 cells, HeLa cells. Positive IHC detected in human lung cancer tissue, human breast cancer tissue, human cervical cancer tissue. Observed molecular weight by Western-blot: 90 kDa
-
Tested applications
ELISA, WB, IHC, IF, IP
-
Species reactivity
Human; other species not tested.
-
Alternative names
ribonucleotide reductase M1 antibody; RIR1 antibody; RR1 antibody; RRM1 antibody
-
Isotype
Mouse IgG2b
-
Preparation
This antibody was obtained by immunization of RRM1 recombinant protein (Accession Number: NM_001033). Purification method: Protein A purified.
-
Clonality
Monoclonal
-
Formulation
PBS with 0.1% sodium azide and 50% glycerol pH 7.3.
-
Storage instructions
Store at -20℃. DO NOT ALIQUOT
-
Applications
Recommended Dilution:
WB: 1:500-1:5000
IP: 1:500-1:5000
IHC: 1:20-1:200
IF: 1:20-1:200
-
Validations
K-562 cells were subjected to SDS PAGE followed by western blot with Catalog No:107512(RRM1 antibody) at dilution of 1:1000
Immunohistochemical of paraffin-embedded human lung cancer using Catalog No:107512(RRM1 antibody) at dilution of 1:100 (under 10x lens)
Immunohistochemical of paraffin-embedded human lung cancer using Catalog No:107512(RRM1 antibody) at dilution of 1:100 (under 40x lens)
IP Result of anti-RRM1 (IP:Catalog No:107512, 5ug; Detection:Catalog No:107512 1:1000) with K-562 cells lysate 3440ug.
Immunofluorescent analysis of HepG2 cells using Catalog No:107512(RRM1 Antibody) at dilution of 1:50 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Mouse IgG(H+L)
-
Background
Ribonucleoside-diphosphate reductase functions as a heterodimer of a large and a small subunits in deoxyribonucleotide synthesis. RRM1 constitutes to the large subunit (R1) of ribonucleotide reductase, and it can either form heterodimer with small subunit RRM or RRM2B(PMID:16376858). RRM1 provides the precursors necessary for DNA synthesis. RRM1 can not be detected in quiescent cells, while its mRNA and protein are present throughout the cell cycle in cycling cells(PMID:8188248). Researches showed that RRM1 is involved in carcinogenesis, tumor progression, and the resistance of non-small-cell lung cancer (NSCLC) to treatment. Low level expression of RRM1 in NSCLC is associated with poor survival(PMID:17314339).
-
References
- Ko JJ, Klimowicz AC, Jagdis A. ATM, THMS, and RRM1 protein expression in nasopharyngeal carcinomas treated with curative intent. Head & neck. 2015.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"